Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanlai Sun

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
International Journal of Surgery (London, England)|February 18, 2026
Efficacy and safety of tislelizumab as neoadjuvant treatment in patients with stage II-III microsatellite instability-high/mismatch repair-deficient colorectal cancer: a single-arm, multicenter, open-label, prospective, phase II studyGong Chen, Yao Ye, Yue Liu, et al.
Eclinicalmedicine|July 17, 2025
Total neoadjuvant therapy integrating long-course radiotherapy with trifluridine/tipiracil for locally advanced rectal cancer: a single-arm, multicenter phase 2 trialXue Dou, Lina Zhao, Zhenyu Ma, et al.
Clinical Epigenetics|October 31, 2020
Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical studyJianping Wang, Side Liu, Hui Wang, et al.
International Journal of Surgery (London, England)|May 20, 2025
Optimizing lymph node evaluation in colorectal mucinous adenocarcinoma: a multicenter and population-based studyQiying Yin, Yanlai Sun, Changqing Jing, et al.
Journal of Gastrointestinal Oncology|March 12, 2026
Clinicopathological characteristics and prognosis of patients with mucinous adenocarcinoma originating from the left colon, right colon, or rectum: a nationwide retrospective study in ChinaBingxu Liu, Haoqing He, Xu Guan, et al.
Cancer Cell|October 3, 2025
Neoadjuvant treatment of IBI310 plus sintilimab in locally advanced MSI-H/dMMR colon cancer: A randomized phase 1b studyFeng Wang, Gong Chen, Meng Qiu, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
International Journal of Surgery (London, England)|February 18, 2026
Efficacy and safety of tislelizumab as neoadjuvant treatment in patients with stage II-III microsatellite instability-high/mismatch repair-deficient colorectal cancer: a single-arm, multicenter, open-label, prospective, phase II studyGong Chen, Yao Ye, Yue Liu, et al.
Eclinicalmedicine|July 17, 2025
Total neoadjuvant therapy integrating long-course radiotherapy with trifluridine/tipiracil for locally advanced rectal cancer: a single-arm, multicenter phase 2 trialXue Dou, Lina Zhao, Zhenyu Ma, et al.
Clinical Epigenetics|October 31, 2020
Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical studyJianping Wang, Side Liu, Hui Wang, et al.
International Journal of Surgery (London, England)|May 20, 2025
Optimizing lymph node evaluation in colorectal mucinous adenocarcinoma: a multicenter and population-based studyQiying Yin, Yanlai Sun, Changqing Jing, et al.
Journal of Gastrointestinal Oncology|March 12, 2026
Clinicopathological characteristics and prognosis of patients with mucinous adenocarcinoma originating from the left colon, right colon, or rectum: a nationwide retrospective study in ChinaBingxu Liu, Haoqing He, Xu Guan, et al.
Cancer Cell|October 3, 2025
Neoadjuvant treatment of IBI310 plus sintilimab in locally advanced MSI-H/dMMR colon cancer: A randomized phase 1b studyFeng Wang, Gong Chen, Meng Qiu, et al.
Pageof 4